Regeneron Presents at Barclays Healthcare Conference

Biotech company discusses commercial and investor relations updates.

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Regeneron Pharmaceuticals, Inc. participated in the Barclays 28th Annual Global Healthcare Conference in Miami, Florida. Marion McCourt, Head of Commercial, and Ryan Crowe, Head of Investor Relations, represented the company and provided opening remarks to kick off the conference session.

Why it matters

As a major pharmaceutical company, Regeneron's participation in high-profile industry conferences like the Barclays Healthcare Conference provides insight into the company's strategic priorities, product pipeline, and investor relations efforts - all of which are important for understanding the overall health and direction of the business.

The details

During the conference session, Regeneron executives discussed the company's commercial operations and investor relations activities, though the specific details of their presentation were not included in the source material provided.

  • The Barclays 28th Annual Global Healthcare Conference took place on March 10, 2026.

The players

Regeneron Pharmaceuticals, Inc.

A major American biotechnology company that develops and commercializes medicines for the treatment of serious medical conditions.

Marion McCourt

The Head of Commercial at Regeneron Pharmaceuticals, Inc.

Ryan Crowe

The Head of Investor Relations at Regeneron Pharmaceuticals, Inc.

Got photos? Submit your photos here. ›

What they’re saying

“Very happy to have Regeneron here with us today to kick off the morning here at the Barclays Global Healthcare Conference.”

— Ellie Merle, Biotech Analyst, Barclays (Barclays Bank PLC)

The takeaway

Regeneron's participation in high-profile industry events like the Barclays Healthcare Conference provides valuable insights into the company's strategic priorities and performance as a leading biopharmaceutical firm.